Literature DB >> 19775832

Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes.

Carmen C Popescu1, Ivo A Olivotto, Wayne A Beckham, Will Ansbacher, Sergei Zavgorodni, Richard Shaffer, Elaine S Wai, Karl Otto.   

Abstract

PURPOSE: Volumetric modulated arc therapy (VMAT) is a novel extension of conventional intensity-modulated radiotherapy (cIMRT), in which an optimized three-dimensional dose distribution may be delivered in a single gantry rotation. VMAT is the predecessor to RapidArc (Varian Medical System). This study compared VMAT with cIMRT and with conventional modified wide-tangent (MWT) techniques for locoregional radiotherapy for left-sided breast cancer, including internal mammary nodes. METHODS AND MATERIALS: Therapy for 5 patients previously treated with 50 Gy/25 fractions using nine-field cIMRT was replanned with VMAT and MWT. Comparative endpoints were planning target volume (PTV) dose homogeneity, doses to surrounding structures, number of monitor units, and treatment delivery time.
RESULTS: For VMAT, two 190 degrees arcs with 2-cm overlapping jaws were required to optimize over the large treatment volumes. Treatment plans generated using VMAT optimization resulted in PTV homogeneity similar to that of cIMRT and MWT. The average heart volumes receiving >30 Gy for VMAT, cIMRT, and MWT were 2.6% +/- 0.7%, 3.5% +/- 0.8%, and 16.4% +/- 4.3%, respectively, and the average ipsilateral lung volumes receiving >20 Gy were 16.9% +/- 1.1%, 17.3% +/- 0.9%, and 37.3% +/- 7.2%, respectively. The average mean dose to the contralateral medial breast was 3.2 +/- 0.6 Gy for VMAT, 4.3 +/- 0.4 Gy for cIMRT, and 4.4 +/- 4.7 Gy for MWT. The healthy tissue volume percentages receiving 5 Gy were significantly larger with VMAT (33.1% +/- 2.1%) and IMRT (45.3% +/- 3.1%) than with MWT (19.4% +/- 3.7%). VMAT reduced the number of monitor units by 30% and the treatment time by 55% compared with cIMRT.
CONCLUSIONS: VMAT achieved similar PTV coverage and sparing of organs at risk, with fewer monitor units and shorter delivery time than cIMRT.

Entities:  

Mesh:

Year:  2010        PMID: 19775832     DOI: 10.1016/j.ijrobp.2009.05.038

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  112 in total

1.  Comparative analysis of SmartArc-based dual arc volumetric-modulated arc radiotherapy (VMAT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Hui-Min Ting; Su-Hua Lo; Yu-Wen Wang; Chiu-Ching Tuan; Fu-Min Fang; Te-Jen Su
Journal:  J Appl Clin Med Phys       Date:  2011-11-15       Impact factor: 2.102

Review 2.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

3.  Chest wall radiotherapy with volumetric modulated arcs and the potential role of flattening filter free photon beams.

Authors:  S Subramaniam; S Thirumalaiswamy; C Srinivas; G A Gandhi; M Kathirvel; K K Kumar; S Mallik; M Babaiah; Y Pawar; A Clivio; A Fogliata; P Mancosu; G Nicolini; E Vanetti; L Cozzi
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

4.  RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study.

Authors:  J M Park; K Kim; E K Chie; C H Choi; S J Ye; S W Ha
Journal:  Br J Radiol       Date:  2012-07       Impact factor: 3.039

5.  RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma.

Authors:  G Z Gong; Y Yin; L G Xing; Y J Guo; T Liu; J Chen; J Lu; C Ma; T Sun; T Bai; G Zhang; R Wang
Journal:  Strahlenther Onkol       Date:  2012-02-08       Impact factor: 3.621

6.  Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy.

Authors:  Marguerite Tyran; Agnes Tallet; Michel Resbeut; Marjorie Ferre; Veronique Favrel; Pierre Fau; Laurence Moureau-Zabotto; Julien Darreon; Laurence Gonzague; Ahcene Benkemouche; Leonel Varela-Cagetti; Naji Salem; Bertrand Farnault; Marie-Aimee Acquaviva; Hugues Mailleux
Journal:  J Appl Clin Med Phys       Date:  2018-06-30       Impact factor: 2.102

7.  When is better best? A multiobjective perspective.

Authors:  Mark H Phillips; Clay Holdsworth
Journal:  Med Phys       Date:  2011-03       Impact factor: 4.071

8.  Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy?

Authors:  Enzhuo M Quan; Joe Y Chang; Zhongxing Liao; Tingyi Xia; Zhiyong Yuan; Hui Liu; Xiaoqiang Li; Cody A Wages; Radhe Mohan; Xiaodong Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-01       Impact factor: 7.038

9.  Node-positive left-sided breast cancer: does VMAT improve treatment plan quality with respect to IMRT?

Authors:  M Pasler; D Georg; S Bartelt; J Lutterbach
Journal:  Strahlenther Onkol       Date:  2013-03-24       Impact factor: 3.621

10.  Application of volumetric modulated arc therapy (VMAT) in a dual-vendor environment.

Authors:  Barbara Dobler; Karin Weidner; Oliver Koelbl
Journal:  Radiat Oncol       Date:  2010-10-25       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.